400 related articles for article (PubMed ID: 15814741)
81. Mdm2 promotes systemic lupus erythematosus and lupus nephritis.
Allam R; Sayyed SG; Kulkarni OP; Lichtnekert J; Anders HJ
J Am Soc Nephrol; 2011 Nov; 22(11):2016-27. PubMed ID: 21949095
[TBL] [Abstract][Full Text] [Related]
82. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
83. Terminal deoxynucleotidyltransferase deficiency decreases autoimmune disease in diabetes-prone nonobese diabetic mice and lupus-prone MRL-Fas(lpr) mice.
Robey IF; Peterson M; Horwitz MS; Kono DH; Stratmann T; Theofilopoulos AN; Sarvetnick N; Teyton L; Feeney AJ
J Immunol; 2004 Apr; 172(7):4624-9. PubMed ID: 15034081
[TBL] [Abstract][Full Text] [Related]
84. Co-stimulation via CD28 induces activation of a refractory subset of MRL-lpr/lpr T lymphocytes.
Clements JL; Winslow G; Donahue C; Cooper SM; Allison JP; Budd RC
Int Immunol; 1993 Nov; 5(11):1451-60. PubMed ID: 7903158
[TBL] [Abstract][Full Text] [Related]
85. Prolonged exposure of T cells to TNF down-regulates TCR zeta and expression of the TCR/CD3 complex at the cell surface.
Isomäki P; Panesar M; Annenkov A; Clark JM; Foxwell BM; Chernajovsky Y; Cope AP
J Immunol; 2001 May; 166(9):5495-507. PubMed ID: 11313388
[TBL] [Abstract][Full Text] [Related]
86. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-gamma expression, and diminishes systemic pathology.
Kikawada E; Lenda DM; Kelley VR
J Immunol; 2003 Apr; 170(7):3915-25. PubMed ID: 12646661
[TBL] [Abstract][Full Text] [Related]
87. Role of Fas and Treg cells in fracture healing as characterized in the fas-deficient (lpr) mouse model of lupus.
Al-Sebaei MO; Daukss DM; Belkina AC; Kakar S; Wigner NA; Cusher D; Graves D; Einhorn T; Morgan E; Gerstenfeld LC
J Bone Miner Res; 2014 Jun; 29(6):1478-91. PubMed ID: 24677136
[TBL] [Abstract][Full Text] [Related]
88. A subset of CD4+ T cells expressing early activation antigen CD69 in murine lupus: possible abnormal regulatory role for cytokine imbalance.
Ishikawa S; Akakura S; Abe M; Terashima K; Chijiiwa K; Nishimura H; Hirose S; Shirai T
J Immunol; 1998 Aug; 161(3):1267-73. PubMed ID: 9686587
[TBL] [Abstract][Full Text] [Related]
89. Impaired Fas signaling pathway is involved in defective T cell apoptosis in autoimmune murine arthritis.
Zhang J; Bárdos T; Mikecz K; Finnegan A; Glant TT
J Immunol; 2001 Apr; 166(8):4981-6. PubMed ID: 11290777
[TBL] [Abstract][Full Text] [Related]
90. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
Benihoud K; Bonardelle D; Bobé P; Kiger N
Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
[TBL] [Abstract][Full Text] [Related]
91. Mitogen-induced IL-2 production and proliferation at defined stages of T helper cell development.
Chang JF; Thomas CA; Kung JT
J Immunol; 1991 Aug; 147(3):860-6. PubMed ID: 1830601
[TBL] [Abstract][Full Text] [Related]
92. A fas antigen receptor mutation allows development of toxic shock syndrome toxin-1-induced lethal shock in V beta 8.2 T-cell receptor transgenic mice.
Cullen CM; Bonventre PF; Heeg H; Bluethmann H; Mountz JD; Edwards CK
Pathobiology; 1995; 63(6):293-304. PubMed ID: 8738468
[TBL] [Abstract][Full Text] [Related]
93. B cells and dendritic cells from V kappa 8 light chain transgenic mice activate MRL-lpr/gld CD4+ T cells.
Beaudette-Zlatanova BC; Ling T; Shlomchik MJ; Marshak-Rothstein A; Rifkin IR
J Immunol; 2006 Jul; 177(1):45-52. PubMed ID: 16785497
[TBL] [Abstract][Full Text] [Related]
94. IL-2 Modulates the TCR Signaling Threshold for CD8 but Not CD4 T Cell Proliferation on a Single-Cell Level.
Au-Yeung BB; Smith GA; Mueller JL; Heyn CS; Jaszczak RG; Weiss A; Zikherman J
J Immunol; 2017 Mar; 198(6):2445-2456. PubMed ID: 28159902
[TBL] [Abstract][Full Text] [Related]
95. Reducing FLI1 levels in the MRL/lpr lupus mouse model impacts T cell function by modulating glycosphingolipid metabolism.
Richard EM; Thiyagarajan T; Bunni MA; Basher F; Roddy PO; Siskind LJ; Nietert PJ; Nowling TK
PLoS One; 2013; 8(9):e75175. PubMed ID: 24040398
[TBL] [Abstract][Full Text] [Related]
96. The T Cell Receptor Repertoire in Neuropsychiatric Systemic Lupus Erythematosus.
Moore E; Huang MW; Jain S; Chalmers SA; Macian F; Putterman C
Front Immunol; 2020; 11():1476. PubMed ID: 32765512
[No Abstract] [Full Text] [Related]
97. Sunlight triggers cutaneous lupus through a CSF-1-dependent mechanism in MRL-Fas(lpr) mice.
Menke J; Hsu MY; Byrne KT; Lucas JA; Rabacal WA; Croker BP; Zong XH; Stanley ER; Kelley VR
J Immunol; 2008 Nov; 181(10):7367-79. PubMed ID: 18981160
[TBL] [Abstract][Full Text] [Related]
98. Fas expression on antigen-specific T cells has costimulatory, helper, and down-regulatory functions in vivo for cytotoxic T cell responses but not for T cell-dependent B cell responses.
Puliaeva I; Puliaev R; Shustov A; Haas M; Via CS
J Immunol; 2008 Nov; 181(9):5912-29. PubMed ID: 18941180
[TBL] [Abstract][Full Text] [Related]
99. CD4 T cell-dependent autoimmunity against a melanocyte neoantigen induces spontaneous vitiligo and depends upon Fas-Fas ligand interactions.
Lambe T; Leung JC; Bouriez-Jones T; Silver K; Makinen K; Crockford TL; Ferry H; Forrester JV; Cornall RJ
J Immunol; 2006 Sep; 177(5):3055-62. PubMed ID: 16920942
[TBL] [Abstract][Full Text] [Related]
100. Unique primed status of microglia under the systemic autoimmune condition of lupus-prone mice.
Nomura A; Noto D; Murayama G; Chiba A; Miyake S
Arthritis Res Ther; 2019 Dec; 21(1):303. PubMed ID: 31888754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]